The purpose of this study is to reduce the exposure of broad-spectrum antimicrobials by optimizing the rapid detection of CAP pathogens and improving rates of de-escalation following negative cultures. To accomplish this, we will perform a 3-year, pragmatic, multicenter 2 X 2 factorial cluster randomized controlled trial with four arms: a) rapid diagnostic testing b) pharmacist-led de-escalation c) rapid diagnostic testing + pharmacist-led de-escalation and d) usual care
Community-Acquired Pneumonia, Antimicrobial Stewardship, Point-of-Care Testing
The purpose of this study is to reduce the exposure of broad-spectrum antimicrobials by optimizing the rapid detection of CAP pathogens and improving rates of de-escalation following negative cultures. To accomplish this, we will perform a 3-year, pragmatic, multicenter 2 X 2 factorial cluster randomized controlled trial with four arms: a) rapid diagnostic testing b) pharmacist-led de-escalation c) rapid diagnostic testing + pharmacist-led de-escalation and d) usual care
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia
-
Indian River Hospital, Vero Beach, Florida, United States, 32960
Weston Hospital/Cleveland Clinic Florida, Weston, Florida, United States, 33331
Akron General Hospital, Akron, Ohio, United States, 44307
Avon Hospital, Avon, Ohio, United States, 44011
Lutheran Hospital, Cleveland, Ohio, United States, 44113
Cleveland Clinic Main Campus, Cleveland, Ohio, United States, 44195
Euclid Hospital, Euclid, Ohio, United States, 44119
Fairview Hospital, Fairview Park, Ohio, United States, 44111
Marymount Hospital, Garfield Heights, Ohio, United States, 44125
Hillcrest Hospital, Mayfield Heights, Ohio, United States, 44124
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
The Cleveland Clinic,
Michael Rothberg, M.D., PRINCIPAL_INVESTIGATOR, The Cleveland Clinic
2026-06-30